Pharmacokinetics of 2'-fluoro-5-[11C]-methyl-1-β-D-arabinofuranosyluracil ([11C]FMAU) in monkeys.

被引：0
|
作者：
Bading, JR [1 ]
Alauddin, MM [1 ]
Fissekis, JD [1 ]
Kirkman, E [1 ]
Vail, A [1 ]
Conti, PS [1 ]
机构：
[1] Univ So Calif, Los Angeles, CA USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2000年 / 41卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1038
引用
收藏
页码：234P / 234P
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics and radiation dosimetry of 2′-fluoro-5-11C-methyl-1-β-D-arabinofuranosyluracil (11C-FMAU) in humans.
    Bading, JR
    Alauddin, MM
    Shahinian, AH
    Conti, PS
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 266P - 266P
  • [2] Pharmacokinetics of the thymidine analog 2′-fluoro-5-[14C]-methyl-1-β-D-arabinofuranosyluracil ([14C]FMAU) in rat prostate tumor cells
    Bading, JR
    Shahinian, AH
    Bathija, P
    Conti, PS
    NUCLEAR MEDICINE AND BIOLOGY, 2000, 27 (04) : 361 - 368
  • [3] Tumor imaging with 2′-fluoro-5-11C-methyl-1-β-D-arabinofuranosyluracil (11C-FMAU):: Initial clinical studies.
    Conti, PS
    Bading, JR
    Alauddin, MM
    Fissekis, JD
    Berenji, B
    Hayles, S
    Jadvar, H
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 26P - 26P
  • [4] Preparation of [11C]-thymidine and [11C]-2'-arabino-2'-fluoro-β-5-methyl-uridine (FMAU)
    Div Medicin. Chemistry/Pharmaceutics, University of Kentucky, Lexington, KY 40536-0082, United States
    Journal of Labelled Compounds and Radiopharmaceuticals, 1995, 36 (12): : 1133 - 1145
  • [5] Preliminary clinical imaging trails with the tumor imaging 2′-deoxy-2′-fluoro-5-[11C]-methyl-1-β-D-arabinofuranosyl-uracil (11C-FMAU):: Comparison studies with FDG
    Conti, PS
    Bading, J
    Alauddin, MM
    Fissekis, JD
    Berenji, B
    RADIOLOGY, 2002, 225 : 660 - 660
  • [6] SYNTHESIS OF 2'-FLUORO-5-[C-11-METHYL]-1-BETA-D-ARABINOFURANOSYLURACIL (C-11-FMAU) FOR USE IN IN-VIVO IMAGING BY POSITRON EMISSION TOMOGRAPHY (PET)
    ALAUDDIN, MM
    FISSEKIS, JR
    CONTI, PS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 45 - NUCL
  • [7] SYNTHESIS OF 2'-FLUORO-5-[C-11]-METHYL-1-BETA-D-ARABINOFURANOSYLURACIL ([C-11]-FMAU) - A POTENTIAL NUCLEOSIDE ANALOG FOR IN-VIVO STUDY OF CELLULAR PROLIFERATION WITH PET
    CONTI, PS
    ALAUDDIN, MM
    FISSEKIS, JR
    SCHMALL, B
    WATANABE, KA
    NUCLEAR MEDICINE AND BIOLOGY, 1995, 22 (06) : 783 - 789
  • [8] Synthesis of 1-(2′-deoxy-2′-fluoro-β-D-arabinofuranosyl)-[Methyl-11C]thymine ([11C]FMAU) via a Stille cross-coupling reaction with [11C]methyl iodide
    Samuelsson, L
    Långström, B
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2003, 46 (03): : 263 - 272
  • [9] Pharmacokinetics of the thymidine analog 2′-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats
    Bading, JR
    Shahinian, AH
    Vail, A
    Bathija, P
    Koszalka, GW
    Koda, RT
    Alauddin, MM
    Fissekis, JD
    Conti, PS
    NUCLEAR MEDICINE AND BIOLOGY, 2004, 31 (04) : 407 - 418
  • [10] Pre-clinical studies of 2'-fluoro-5-[C-11]-methyl-1-beta-D-arabinofuranosyluracil (FMAU): A potential PET indicator of tumor proliferation.
    Conti, PS
    Anderson, JH
    Wong, DF
    Bading, JR
    Alauddin, MM
    Ravert, HT
    MAtthews, WB
    Musachio, JL
    Dannals, RF
    Scheffel, U
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 419 - 419
12345